CTD Holdings Inc (CTDH):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CTD Holdings Inc (CTDH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8075
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CTD Holdings Inc (CTDH), formerly Cyclodextrin Technologies Development Inc is a biotechnology company that develops, manufactures and distributes cyclodextrins products. The company’s products include aquaplex, trappsol and trappsol cyclo. It provides trappsol cyclo, which is a hydroxypropyl beta cyclodextrin available in the form of liquid and powder for the treatment of Niemann Pick Type C disease. CTDH also supports various research studies. The company’s products are used in chronic arterial occlusive disease, control hypotension during surgery, induction of labor, buerger’s disease treatment, antiulcerant, throat disinfectant, coronary dilator, antifungal and other applications. It caters to diagnostics, industrial chemical industries, pharmaceutical and chemical supply distributors. CTDH is headquartered in Gainesville, Florida, the US.

CTD Holdings Inc (CTDH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CTD Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CTD Holdings Plans to Enter into Research Agreement with Kerwin Research Center 10
Equity Offering 11
CTD Holdings Raises USD2 Million in Private Placement of Units 11
CTD Holdings Raises USD2 Million in Private Placement of Units 12
CTD Holdings Raises USD2 Million in Private Placement of Units 13
CTD Holdings Raises USD0.6 Million in Private Placement of Shares 14
CTD Holdings Raises USD1.3 Million in Private Placement of Shares 15
CTD Raises USD1.7 Million in Private Placement of Shares 16
CTD Holdings Raises USD1 Million in Private Placement of Shares 18
CTD Holdings Completes Private Placement Of Shares For US$0.5 Million 19
CTD Holdings Raises Funds through Private Placement of Shares and Warrants 20
CTD Holdings Inc – Key Competitors 21
CTD Holdings Inc – Key Employees 22
CTD Holdings Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Corporate Communications 24
Mar 20, 2018: CTD Holdings Names Randall M. Toig As Board Director 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
CTD Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CTD Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CTD Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CTD Holdings Plans to Enter into Research Agreement with Kerwin Research Center 10
CTD Holdings Raises USD2 Million in Private Placement of Units 11
CTD Holdings Raises USD2 Million in Private Placement of Units 12
CTD Holdings Raises USD2 Million in Private Placement of Units 13
CTD Holdings Raises USD0.6 Million in Private Placement of Shares 14
CTD Holdings Raises USD1.3 Million in Private Placement of Shares 15
CTD Raises USD1.7 Million in Private Placement of Shares 16
CTD Holdings Raises USD1 Million in Private Placement of Shares 18
CTD Holdings Completes Private Placement Of Shares For US$0.5 Million 19
CTD Holdings Raises Funds through Private Placement of Shares and Warrants 20
CTD Holdings Inc, Key Competitors 21
CTD Holdings Inc, Key Employees 22
CTD Holdings Inc, Subsidiaries 23

List of Figures
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CTD Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CTD Holdings Inc (CTDH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Berjaya Sports Toto Berhad:企業の戦略・SWOT・財務情報
    Berjaya Sports Toto Berhad - Strategy, SWOT and Corporate Finance Report Summary Berjaya Sports Toto Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Immunovia AB (IMMNOV):医療機器:M&Aディール及び事業提携情報
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Arab African International Bank:企業の戦略・SWOT・財務情報
    Arab African International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab African International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • ALSTOM SA:企業の戦略・SWOT・財務分析
    ALSTOM SA - Strategy, SWOT and Corporate Finance Report Summary ALSTOM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Quest Diagnostics Incorporated:企業のM&A・事業提携・投資動向
    Quest Diagnostics Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Quest Diagnostics Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Verizon Communications Inc (VZ):企業の財務・戦略的SWOT分析
    Verizon Communications Inc (VZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Toray Industries Inc (3402):電力:M&Aディール及び事業提携情報
    Summary Toray Industries Inc (Toray) is a provider of advanced materials. The company's product portfolio includes fibers, fashion apparel, plastics, chemicals, IT-related products, composite materials, life sciences products, and medical devices, pharmaceuticals, and optical products. It provides i …
  • Country Club Hospitality & Holidays Ltd.
    Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report Summary Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Sprint Bioscience AB (SPRINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sprint Bioscience AB (Sprint Bioscience) is a developer of pharmaceutical products in the areas of cancer and metabolism. The company develops STK25, a drug candidate against a new target protein for the treatment of type 2 diabetes; VPS34, a drug candidate for the treatment of various types …
  • Enbridge Inc (ENB):企業の財務・戦略的SWOT分析
    Enbridge Inc (ENB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • American Builders & Contractors Supply Co Inc:企業の戦略・SWOT・財務情報
    American Builders & Contractors Supply Co Inc - Strategy, SWOT and Corporate Finance Report Summary American Builders & Contractors Supply Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • China Aviation Oil (Singapore) Corp Ltd (G92)
    China Aviation Oil (Singapore) Corp Ltd (G92) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Unitika Ltd (3103):企業の財務・戦略的SWOT分析
    Unitika Ltd (3103) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Standard Bank Group Ltd (SBK):電力:M&Aディール及び事業提携情報
    Summary Standard Bank Group Ltd (SBG) is a provider of integrated financial services such as personal and business banking, corporate and investment banking, and wealth management and insurance solutions. The personal and business banking portfolio consists of transactional products, lending product …
  • C. R. Bard Inc (BCR)-医療機器分野:企業M&A・提携分析
    Summary C. R. Bard Inc (Bard) is a medical device company, which offers medical, surgical, diagnostic and patient care devices related to vascular disorders, urology disorders, cancer diagnosis and treatment and surgical specialties. Its major products include devices for the treatment of peripheral …
  • Lead Discovery Center GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Lead Discovery Center GmbH (LDC), a subsidiary of Max Planck Innovation GmbH is a biomedical research company that offers development of novel drugs and therapies. The company develops drugs and therapies for diseases such as neurodegenerative cardiovascular diseases, cancer, inflammatory di …
  • PCL Constructors Inc:企業の戦略的SWOT分析
    PCL Constructors Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Nuffield Health:企業の戦略的SWOT分析
    Nuffield Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • 1414 Degrees Ltd (14D):企業の財務・戦略的SWOT分析
    1414 Degrees Ltd (14D) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • ProMIS Neurosciences Inc (PMN)-医療機器分野:企業M&A・提携分析
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd. is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆